{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:43:13Z","timestamp":1794634993545,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Photochemistry and Photobiology B: Biology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jphotobiol.2016.12.018","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T08:02:18Z","timestamp":1482048138000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["A PSMA-targeted theranostic agent for photodynamic therapy"],"prefix":"10.1016","volume":"167","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-181X","authenticated-orcid":false,"given":"Samit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Lisok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il","family":"Minn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrudula","family":"Pullambhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Wharram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-6562","authenticated-orcid":false,"given":"Yuchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-1111","authenticated-orcid":false,"given":"Jiefu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaver M.","family":"Bhujwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-7191","authenticated-orcid":false,"given":"Sridhar","family":"Nimmagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie C.","family":"Mease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.20074","article-title":"Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen","volume":"61","author":"Huang","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0010","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1073\/pnas.1735443100","article-title":"The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy","volume":"100","author":"Schuelke","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0015","first-page":"3629","article-title":"Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium","volume":"57","author":"Liu","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0020","first-page":"3192","article-title":"Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature","volume":"59","author":"Chang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0025","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1634\/theoncologist.11-9-1034","article-title":"Photodynamic therapy in oncology","volume":"11","author":"Triesscheijn","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0030","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1088\/0031-9155\/53\/9\/R01","article-title":"The physics, biophysics and technology of photodynamic therapy","volume":"53","author":"Wilson","year":"2008","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0035","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1021\/cr900300p","article-title":"Imaging and photodynamic therapy: mechanisms, monitoring, and optimization","volume":"110","author":"Celli","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0040","first-page":"351","article-title":"The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours","volume":"8","author":"Maziere","year":"1991","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000030066","article-title":"Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates","volume":"20","author":"Lutsenko","year":"1999","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0050","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/S0968-0896(02)00242-0","article-title":"An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells","volume":"10","author":"Swamy","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0960-894X(03)00120-3","article-title":"Synthesis and biological activities of phthalocyanine-estradiol conjugates","volume":"13","author":"Khan","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0060","first-page":"161","article-title":"Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation","volume":"24","author":"Stevens","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0065","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-05-0426","article-title":"Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates","volume":"65","author":"Savellano","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1039\/b708320c","article-title":"Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosensitizer conjugates suitable for photodynamic therapy","volume":"6","author":"Kuimova","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0075","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0080","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1021\/bc2002715","article-title":"Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate","volume":"22","author":"Nakajima","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnumed.114.149526","article-title":"Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?","volume":"56","author":"Watanabe","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/pros.20909","article-title":"In vitro targeted photodynamic therapy with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen","volume":"69","author":"Liu","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0095","first-page":"777","article-title":"Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8\/-3 cascade pathway","volume":"36","author":"Liu","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2010.04.003","article-title":"Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption","volume":"296","author":"Liu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0105","first-page":"241","article-title":"Prostate-specific membrane antigen as a target for cancer imaging and therapy","volume":"59","author":"Kiess","year":"2015","journal-title":"Q. J. Nucl. Med. Mol. Imaging Med."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbrc.2009.10.017","article-title":"A low molecular weight PSMA-based fluorescent imaging agent for cancer","volume":"390","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm800994j","article-title":"A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer","volume":"52","author":"Maresca","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0120","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-11-1357","article-title":"2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-urei do)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0125","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bc3003919","article-title":"Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen","volume":"23","author":"Chen","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0130","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2967\/jnumed.112.104661","article-title":"Biodistribution, tumor detection and radiation dosimetry of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-18F-fluorobenzyl-l-cysteine (18F-DCFBC), a low molecular weight inhibitor of PSMA, in patients with metastatic prostate cancer","volume":"53","author":"Cho","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0135","series-title":"Annual Meeting of the Society of Nuclear Medicine","first-page":"136P","article-title":"Targeting metastatic prostate cancer (PCA) in patients wtih 123I-MIP1072 and 123I-MIP1095","author":"Barrett","year":"2009"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0140","series-title":"Annual Meeting of the Society of Nuclear Medicine","first-page":"179P","article-title":"Small molecule inhibitors of prostate specific membrane antigen (PSMA) for SPECT: summary of phase I studies in patients with prostate cancer (PCa)","author":"Babich","year":"2012"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00259-012-2069-0","article-title":"[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","article-title":"Initial evaluation of [18F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer","volume":"17","author":"Szabo","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0155","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.7150\/thno.13348","article-title":"For radionuclide imaging and therapy of prostate cancer: clinical status","volume":"5","author":"Lutje","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2016.13","article-title":"PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges","author":"Rowe","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"Supplement 3","key":"10.1016\/j.jphotobiol.2016.12.018_bb0165","first-page":"1212","article-title":"A PSMA-targeted theranostic agent for prostate cancer","volume":"56","author":"Chen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0170","series-title":"Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate Specific Membrane Antigen","author":"Wang","year":"2016"},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0180","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constate (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0190","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/jm801055h","article-title":"Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer","volume":"51","author":"Chen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jphotobiol.2016.12.018_bb0195","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Photochemistry and Photobiology B: Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134416306327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134416306327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:55:35Z","timestamp":1760892935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1011134416306327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"alternative-id":["S1011134416306327"],"URL":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2016.12.018","relation":{},"ISSN":["1011-1344"],"issn-type":[{"value":"1011-1344","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A PSMA-targeted theranostic agent for photodynamic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Photochemistry and Photobiology B: Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2016.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}